Insights

Vaccine Platform Opportunity Artificial Cell Technologies is developing a proprietary peptide platform for delivering vaccines, presenting a viable path to partner on peptide-based delivery systems, adjuvant optimization, and scalable manufacturing for vaccine candidates.

RSV Vaccine Validation Recent RSV microparticle vaccine research achieving protective immune responses in mice signals a translational pathway; sales discussions could focus on collaboration for preclinical-to-clinic programs and potential licensing of their platform for viral vaccines.

Small Team Agility With a lean team of 2–10 employees, there is potential for rapid partnerships, low-friction pilot projects, and flexible engagements, appealing to agile biotech buyers seeking quick time-to-value.

Growing Revenue Current revenue is in the low single to mid single millions; opportunities exist to offer contract development, manufacturing, or clinical services that align with their platform, accelerating revenue while expanding capabilities.

Tech & Infrastructure The tech stack includes cloud and web-focused tools (AWS, WordPress, Shopify) plus security and ad solutions; potential to propose compliant, scalable cloud-based data management, analytics, and digital platform support for R&D, trials, and partner collaboration.

Similar companies to Artificial Cell Technologies

Artificial Cell Technologies Tech Stack

Artificial Cell Technologies uses 8 technology products and services including Google AdSense, Amazon Web Services, Sucuri, and more. Explore Artificial Cell Technologies's tech stack below.

Artificial Cell Technologies's Email Address Formats

Artificial Cell Technologies uses at least 1 email format:
Artificial Cell Technologies Email FormatsExamplePercentage
FLast@artificialcelltech.comJDoe@artificialcelltech.com
100%

Frequently Asked Questions

What is Artificial Cell Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Artificial Cell Technologies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Artificial Cell Technologies's official website and social media links?

Minus sign iconPlus sign icon
Artificial Cell Technologies's official website is artificialcelltech.com and has social profiles on LinkedIn.

How much revenue does Artificial Cell Technologies generate?

Minus sign iconPlus sign icon
As of November 2026, Artificial Cell Technologies's annual revenue is estimated to be $1M - $10M.

What is Artificial Cell Technologies's SIC code and NAICS code?

Minus sign iconPlus sign icon
Artificial Cell Technologies's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Artificial Cell Technologies have currently?

Minus sign iconPlus sign icon
As of November 2026, Artificial Cell Technologies has approximately 3 employees across 2 continents, including North America and Europe. Key team members include Vertrieb: M. K. Explore Artificial Cell Technologies's employee directory with LeadIQ.

What industry does Artificial Cell Technologies belong to?

Minus sign iconPlus sign icon
Artificial Cell Technologies operates in the Biotechnology Research industry.

What technology does Artificial Cell Technologies use?

Minus sign iconPlus sign icon
Artificial Cell Technologies's tech stack includes Google AdSense, Amazon Web Services, Sucuri, WordPress, Funding Choices, Shopify, Amazon ALB and Vimeo.

What is Artificial Cell Technologies's email format?

Minus sign iconPlus sign icon
Artificial Cell Technologies's email format typically follows the pattern of FLast@artificialcelltech.com. Find more Artificial Cell Technologies email formats with LeadIQ.
Artificial Cell Technologies logo

Artificial Cell Technologies

Biotechnology ResearchConnecticut, United States2-10 Employees

Artificial Cell Technologies is a biotechnology research company based in New Haven, Connecticut, focused on developing a proprietary peptide technology into a platform for delivering vaccines. The approach aims to enable vaccine delivery, offering potential solutions for immunization through a modular platform that can be applied to various vaccine targets. The company’s work is positioned within the biotechnology research industry, addressing needs in vaccine development and delivery. Founded and staffed by a small team, Artificial Cell Technologies has engaged in recent work such as creating a wholly synthetic RSV microparticle vaccine that elicited a protective immune response in mice while reducing pulmonary inflammation. The firm targets researchers and developers in the vaccine field seeking innovative delivery methods to improve immunogenicity and safety.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Artificial Cell Technologies's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.